Global Veterinary Molecular Diagnostic Market(2018-2025)-GMI Research Global Veterinary Molecular Diagnostic Market | Page 2
viruses from many animal species, including pathogens of cattle, cats, dogs,
horses, and others. Nucleic acid diagnostic techniques such as polymerase
chain reaction (PCR) is widely adopted molecular diagnostic tools used for
animals to rapidly screen large numbers of samples during disease outbreaks.
For instance, European Food Safety Authority stated that approximately 320,000
cases of foodborne and zoonotic diseases are reported each year across the
globe.
Request Sample Pages : https://tinyurl.com/ybrbh62n
Rising prevalence of zoonotic disease, increasing diagnosis rate due to the rise
in spending on animal health care are the major driving factors which are
expected to boost the growth of veterinary molecular diagnostic market during
the forecast period. In addition, the introduction of innovative veterinary
diagnostic, and rise in foodborne disease is expected to be one of the crucial
reasons for the growth of veterinary molecular diagnostic market. Moreover,
increasing penetration of molecular diagnostics for veterinary due to the
presence of strong distribution channel, rising urbanization, and with high
disposable incomes pet owners frequently visit the veterinary facilities are some
of the factors boosting the growth of this market. However, the dearth of the
skilled veterinary practitioner and low awareness regarding veterinary molecular
diagnostic in developed and developing countries acts as a restraining factor for
the market.
Various notable players operating in the market, Thermo Fisher Scientific Inc.,
QIAGEN N.V., IDEXX Laboratories Inc., VCA Inc., Biomedica Medizinprodukte
GmbH & Co. KG, HealthGene Corporation, Bioneer, ABAXIS Inc, Neogen
Corporation among others. Most of the company are focusing on strategic
collaboration with the animal health care service provider to increase the
penetration of veterinary molecular diagnostic in emerging economies such as
China, India, Brazil, etc.